Prostate cancer: Increased dementia risk following androgen deprivation therapy?

Authors/Creators

Ralph Martins, Edith Cowan UniversityFollow
Sam Gandy

Abstract

Although the increased use of androgen deprivation therapy for prostate cancer might be improving survival, a recent large retrospective cohort study that analysed hospital medical record data indicates that long therapy duration is associated with an increased risk of Alzheimer's disease.

RAS ID

24432

Document Type

Journal Article

Date of Publication

2016

School

School of Medical Sciences / Centre of Excellence for Alzheimer's Disease Research and Care

Copyright

subscription content

Publisher

Nature

Comments

Martins, R. N., & Gandy, S. (2016). Prostate cancer: Increased dementia risk following androgen deprivation therapy?. Nature Reviews Urology, 13(4), 188-189. Available here

Recommended Citation

Martins, R., & Gandy, S. (2016). Prostate cancer: Increased dementia risk following androgen deprivation therapy?. DOI: https://doi.org/10.1038/nrurol.2016.34